|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Processing Collecting necessary data for PSDV...
|
pSivida 30-Days Moving RatingEstimated Market Risk |
| 2.35 actual daily | 60 % of total potential |

| 0.06 actual daily | 4 % of total potential |

| 0.02 actual daily | 1 % of total potential |
| Increase Risk-Adjusted return of PSDV by adding it to a well-diversified portfolio |
0.81%| 1.24 | 1.23 |
Few days ago at money.msn.com Alimera, pSivida fall further after FDA rejection
MSN Money - Nov 14, 2011
NEW YORK (AP) - Shares of Alimera Sciences Inc. and pSivida Corp. continued to slide Monday as Wall Street assessed the prospects for their retinal disease treatment Iluvien. THE SPARK: The stocks ...
Biotech Wipeout: Alimera, pSivida and Now Emisphere Technologies and Cadence Pharmaceuticals ALIM, PSDV, EMIS, CADX - SmallCap Network
Alimera, pSivida shares take a beating on FDA's Iluvien rejection - FierceBiotech
The Australian
- Australian Life Scientist
- Seeking Alpha |
Few days ago at nz.finance.yahoo.com Australia up 1.1 pct on Italy progress; pSivida slides
Yahoo!Xtra New Zealand News - Nov 14, 2011
Nov 14 (Reuters) - Australian shares gained 1.1 percent on Monday, led by banks and industrial stocks on relief that Italy has moved swiftly to appoint a new prime minister, aiming to end a crisis ... |
Few days ago at www.fnno.com pSivida: New 52-Week Low Set Today (PSDV)
Shares of pSivida (NASDAQ:PSDV) traded today at $3.45, breaking its 52-week low. Approximately 1.1 million shares have changed hands today, as compared to an average 30-day volume of 90,000 shares ... |
Few days ago at www.fnno.com pSivida: New 52-Week Low Set Today (PSDV)
Shares of pSivida (NASDAQ:PSDV) traded today at $3.45, breaking its 52-week low. Approximately 1.1 million shares have changed hands today, as compared to an average 30-day volume of 90,000 shares ... |
Few days ago at www.bloomberg.com Alimera, Psivida Shares Drop After U.S. FDA Rejects Eye Drug for Diabetes
Bloomberg - Nov 10, 2011
By Molly Peterson - Fri Nov 11 21:33:52 GMT 2011 Alimera Sciences Inc. (ALIM) plunged 73 percent and Psivida Corp. (PSDV) fell the most in almost seven years after US regulators rejected the ...
Alimera plunges as FDA asks for new Iluvien trials - BusinessWeek
pSivida Corp. to Hold Monday November 14 Conference Call to Discuss Complete Response Letter for ILUVIEN(R) for DME and pSivida's Product Pipeline - MarketWatch
TheStreet.com
- Business Wire
- StreetInsider.com |